Esperion Theraptc
(ESPR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 208,892 | 103,672 | 219,186 | 217,939 | 304,962 |
| Marketable Securities | 50,441 | N/A | N/A | N/A | N/A |
| Receivables | 22,934 | 21,710 | 21,854 | N/A | 12,388 |
| Inventories | 34,394 | 33,972 | 23,714 | 20,030 | 16,136 |
| Other current assets | 11,173 | 10,328 | 9,770 | 34,163 | 11,566 |
| TOTAL | $328,972 | $170,668 | $275,174 | $272,575 | $345,896 |
| Non-Current Assets | |||||
| PPE Net | 664 | 817 | 970 | 1,123 | 1,276 |
| Intangibles | 56 | 56 | 56 | 56 | 56 |
| Other Non-Current Assets | 51,898 | 53,715 | 4,261 | 4,852 | 6,030 |
| TOTAL | $52,618 | $54,588 | $5,287 | $6,031 | $7,362 |
| Total Assets | $381,590 | $225,256 | $280,461 | $278,606 | $353,258 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 17,559 | 20,745 | 29,353 | 30,342 | 51,975 |
| Accrued Expenses | 7,013 | 3,746 | 2,873 | 7,549 | 7,663 |
| Other current liabilities | 11,295 | 14,048 | 12,469 | 6,353 | 5,392 |
| TOTAL | $73,352 | $78,485 | $82,644 | $97,893 | $94,069 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 5,683 | 3,068 | 3,930 | 2,543 | 1,662 |
| Other Non-Current Liabilities | 504,548 | 508,631 | 501,070 | 450,107 | 355,323 |
| TOTAL | $505,182 | $509,476 | $502,127 | $450,107 | $355,323 |
| Total Liabilities | $578,534 | $587,961 | $584,771 | $548,000 | $449,392 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 62,822 | 29,077 | 28,277 | 28,192 | 27,943 |
| Common Shares | 61 | 27 | 26 | 26 | 26 |
| Retained earnings | -1,106,377 | -1,041,258 | -971,872 | -928,204 | -838,817 |
| Other shareholders' equity | -29 | 2 | 2 | 2 | 2 |
| TOTAL | $-196,944 | $-362,705 | $-304,310 | $-269,394 | $-96,134 |
| Total Liabilities And Equity | $381,590 | $225,256 | $280,461 | $278,606 | $353,258 |